I. Swiatek vs J. Pegula — predicción

Pegula holds the higher ranking (#3 vs #5) and is favored by the fundamental rating method. Yet the Elo gap is tiny (1995 to 2022) and Swiatek's recent trajectory is sharper. Pegula's ranking reflects season-long solidity; Swiatek is trending downward (−2) despite a 9-win streak. This tension—higher-ranked player meeting red-hot challenger—is real and weighs against the odds.

Swiatek's 9-win streak and 8/10 recent form are exceptional. Her quality wins include Rybakina (Elo 2043), a top-5 caliber opponent. Pegula, by contrast, has 6/10 recent and a 4-win streak; her best win is Anisimova (Elo 1923), 50+ Elo below Rybakina. Form clearly favors Swiatek. However, Pegula's deep run at Cincinnati (reaching QF two days ago) signals stamina and tournament readiness despite fatigue; it also raises deep-run fatigue risk for a best-of-3 encounter.

Swiatek has 3 days rest; Pegula, 2. Swiatek played 7 matches in 14 days (heavier load), Pegula 5. The advantage is mild to Swiatek. Pegula's home-crowd context (USA player, Cincinnati) is historically priced by the market and cannot be claimed as an edge. The deep-run fatigue flag for Pegula (QF appearance 48 hours ago) is a tactical risk—she may still be recovering from intensity—but not a guarantee of underperformance in a fresh match.

Head-to-head favors Swiatek 7–5 over 12 meetings, a material historical edge. Recent results are split 2–2, suggesting no trend drift.

Hard court is strong for both: Swiatek 77%, Pegula 74%. The 3-point baseline difference narrows to +0 points surface edge for Swiatek (neutral). Serve is identical (62% for both), and Swiatek's return edge (+5 pts) is modest. These factors do not swing the match; both are hard-court competitors at the elite level.

The model assigns 54% to Swiatek; the market prices her at 72% (1.39 odds). This gap of −24.3% expected value reveals the market is overvaluing the favorite. The model respects Pegula's ranking, recent solidity, and head-to-head record, yielding a closer match than the odds suggest. Swiatek's streak and form quality are genuine, but they do not justify a 72% probability when the ratings are near-parity and Pegula brings the ranking credential.

The bet at 1.39 is unfavorable for Swiatek backers: you are paying 72% odds for a 54% true probability. Conversely, Pegula at +120 (implied 45%) offers value if you credit the ranking, rest advantage, and the model's calibration. This is not a certainty call—Cincinnati hard courts and recent form matter—but the market has priced Swiatek too high.